# Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

> **NCT00869700** · PHASE4 · COMPLETED · sponsor: **University of Cape Town** · enrollment: 18 (actual)

## Conditions studied

- HIV Infections
- Malaria

## Interventions

- **DRUG:** Artemether/Lumefantrine

## Key facts

- **NCT ID:** NCT00869700
- **Lead sponsor:** University of Cape Town
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2010-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00869700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00869700, "Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00869700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*